Improve patient care
Bring testing in-house for a faster turn-around-time and better care with gold-standard PCR-based testing.
Reduce send outs to large centralized labs and eliminate related out of pocket expenses.
In-house testing services enable eligibility for reimbursement.
Maximize lab space and workforce capacity
Small equipment footprint, ease of workflow and automation allow for maximum utilization of resources.
Bring testing to the patient with mobile units.
Retrofitting automobiles such as a 45-foot recreational vehicle (RV) permits mobile testing capable of performing thousands of tests per day.
Flexible offerings to service:
|Specific hot spots||Underserved communities|
- The LuminUltra GeneCount® COVID-19 RT-qPCR Assay Kit has completed the Section IV.C notification process under FDA’s “Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)” and has not been reviewed by FDA.
- Health Canada has granted an Interim Order authorizing all devices included in the submission, to be imported, sold and advertised in Canada, for the duration that the Interim Order is in effect.
- Additional application pending with the European Union for CE IVD.
- All tests must be conducted in accordance with the local laws and regulations.